Loading clinical trials...
Loading clinical trials...
The placental drug Melsmon® is effective for correction of insomnia and other climacteric symptoms in premenopausal women. Decrease of MMI is shown both in groups with Melsmon® and Placebo, but it was...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Inna I. Kovalenko
NCT06419972 · Climacteric Syndrome, Postmenopausal Symptoms, and more
NCT05846698 · Climacteric Syndrome
NCT03897738 · Perimenopause, Climacteric Syndrome
NCT01275807 · Climacteric Syndrome
Scientific Center for Family Health and Human Reproduction Problems, Russia
Irkutsk
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions